Carisma Therapeutics, Inc.
CARM
$0.4411
-$0.0612-12.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 47.46% | -38.84% | -13.80% | 41.18% | 9.45% |
| Total Depreciation and Amortization | -1.20% | -9.23% | 189.02% | -84.94% | 134.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 146.95% | -70.79% | -44.63% | 37.98% | 32.75% |
| Change in Net Operating Assets | -136.98% | 355.57% | 65.06% | -14.07% | -476.08% |
| Cash from Operations | -20.53% | 35.85% | 19.23% | 28.12% | -39.31% |
| Capital Expenditure | -- | -- | 100.00% | -523.53% | 96.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -523.53% | -100.16% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -5.70% | -1.19% | -930.99% | 104.38% | -174.45% |
| Issuance of Common Stock | -- | -- | 6,350.00% | -99.91% | 230.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -0.97% | -34.49% | -731.51% | -94.60% | 1,238.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.34% | 33.45% | 16.54% | 23.41% | -279.52% |